Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sharma, O. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sharma, O. P.
(Chest. 1972;61:320-325.)
© 1972 American College of Chest Physicians

Cutaneous Sarcoidosis: Clinical Features and Management

Om P. Sharma M.D., F.C.C.P.1

1 Pulmonary Disease Section, Department of Medicine, Los Angeles County-University of Southern California Medical School, Los Angeles

Of 145 patients with clinical and histologic evidence of sarcoidosis, 41 (28 percent) presented with various cutaneous manifestations of the disease. The skin lesions have included erythema nodosum in 14 patients, lupus pernio in 6, skin plaques in 9, maculopapular eruptions in 10, and scars in 2 patients. Two patients with erythema nodusum had subcutaneous nodules. Erythema nodosum was accompanied by early reversible bilateral hilar adenopathy in 64 percent of patients. X-ray abnormality cleared in 79 percent of patients. Lupus pernio and skin plaques were associated with a chronic persistent course. Radiologic clearing of the lungs occurred in 22 percent of patients with skin plaques and in none of the patients with lupus pernio. Ocular and bone lesions were seen more often in patients with chronic skin lesions, whereas peripheral lymphadenopathy was frequent in patients with maculopapular rash. Skin lesions do not constitute an absolute indication for therapy. Unsightly lesions may be corrected by oral and topical corticosteroid therapy. Chloroquine has been proved to be effective in selected instances of chronic cutaneous sarcoidosis.




This article has been cited by other articles:


Home page
 RadioGraphicsHome page
T. Koyama, H. Ueda, K. Togashi, S. Umeoka, M. Kataoka, and S. Nagai
Radiologic Manifestations of Sarcoidosis in Various Organs
RadioGraphics, January 1, 2004; 24(1): 87 - 104.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
H. Bachelez, P. Senet, J. Cadranel, A. Kaoukhov, and L. Dubertret
The Use of Tetracyclines for the Treatment of Sarcoidosis
Arch Dermatol, January 1, 2001; 137(1): 69 - 73.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
P. G. Ford, J. L. Jorizzo, and M. G. Hitchcock
Previously Undiagnosed Sarcoidosis in a Patient Presenting With Leonine Facies and Complete Heart Block
Arch Dermatol, June 1, 2000; 136(6): 712 - 714.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
G. Hunninghake
Statement on Sarcoidosis
Am. J. Respir. Crit. Care Med., August 1, 1999; 160(2): 736 - 755.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1972 by the American College of Chest Physicians.